Search

everythinglearnresearchcommunity

for

Search:↓

Scalp cooling and minoxidil can help manage hair loss after chemotherapy.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

New treatments for PCOS focus on insulin resistance and reducing testosterone levels, along with traditional hormone therapies.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Some breast cancer treatments caused long-term hair loss in women, similar to a condition called alopecia areata.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

Tamoxifen may cause female hair loss by increasing androgen receptor expression.

Nutraceuticals that promote hair growth do not reduce tamoxifen's effectiveness in breast cancer treatment.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Targeting vitamin D and androgen receptors may effectively treat triple-negative breast cancer, especially with chemotherapy.

Apigenin and ellagic acid may help manage PCOS symptoms.

Cancer treatments often cause hair loss and damage, affecting patients' mental health.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The document concludes that there is no credible evidence that distant healing works, and it should not be further studied in medical literature.

The document concludes that more research is needed on the hepatitis B vaccine's side effects and the effectiveness of certain treatments for specific diseases.

Hormone treatment for transgender patients may not need to be stopped before surgery, but more research is needed, especially on estrogen.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Healthy aging can be promoted through physical activity, lifestyle changes, and certain treatments.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Some breast cancer chemotherapy can cause permanent hair loss.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

CDK4/6 inhibitors have improved treatment outcomes for certain advanced breast cancer patients.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

Combining letrozole and quercetin in spanlastics may improve breast cancer treatment.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

Certain drugs can worsen hair loss in people prone to androgenetic alopecia.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.